1. Home
  2. SLE vs EVAX Comparison

SLE vs EVAX Comparison

Compare SLE & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Super League Enterprise Inc.

SLE

Super League Enterprise Inc.

HOLD

Current Price

$0.60

Market Cap

3.1M

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$4.85

Market Cap

42.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLE
EVAX
Founded
2014
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
42.7M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
SLE
EVAX
Price
$0.60
$4.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.00
$12.33
AVG Volume (30 Days)
298.8K
108.8K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,568,000.00
$7,650,000.00
Revenue This Year
N/A
$128.77
Revenue Next Year
$29.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
132.17
52 Week Low
$0.55
$1.20
52 Week High
$33.20
$12.15

Technical Indicators

Market Signals
Indicator
SLE
EVAX
Relative Strength Index (RSI) 34.23 42.56
Support Level $0.55 $4.60
Resistance Level $1.04 $6.70
Average True Range (ATR) 0.09 0.53
MACD 0.02 -0.13
Stochastic Oscillator 16.10 13.79

Price Performance

Historical Comparison
SLE
EVAX

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: